Cuba and China sign deals to boost biotechnology cooperation

28 November 2011

Cuba and China have reached agreement to strengthen cooperation on biotechnology, said Cuban Science Minister Jose Miyar Barrueco last week speaking at the 6th Joint Work Meeting for Biotechnological Cooperation, quoted by China’s Xinhau news agency.

Mr Barrueco stressed that it is strategic for the two countries to work together in this sector and there are favorable conditions for the two countries to continue and deepen collaboration in this field, and relevant joint projects have made progress.

Also speaking at the two-day meeting, Zhang Xiaoqiang, vice chairman of China's National Commission for Development and Reform, praised the development of biotechnological cooperation between China and Cuba in the last two years, and suggested the introduction of research achievements to other countries to improve human health.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Biotechnology